Iridex (IRIX) Liabilities and Shareholders Equity (2011 - 2026)

Iridex has reported Liabilities and Shareholders Equity for 16 years, with the latest figure at $27.3 million in Q3 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 13.7% year-over-year to $27.3 million in Q3 2026; TTM through Jul 2026 was $113.0 million, a 9.65% decrease from a year earlier, with the FY2026 full-year figure at $29.2 million, changed 0.05% from the prior year.
• Liabilities and Shareholders Equity was $27.3 million for Q3 2026 at Iridex, down from $28.3 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $48.7 million in Q1 2022, with the low at $27.3 million in Q3 2026.
• Average Liabilities and Shareholders Equity over 5 years is $35.8 million, with a median of $34.2 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity surged 74.07% in 2022, then dropped 22.26% in 2023.
• Over 5 years, Liabilities and Shareholders Equity stood at $42.3 million in 2022, then declined by 18.57% to $34.4 million in 2023, then fell by 15.39% to $29.1 million in 2024, then dropped by 2.68% to $28.4 million in 2025, then declined by 3.86% to $27.3 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $27.3 million (Q3 2026), $28.3 million (Q2 2026), and $29.2 million (Q1 2026), per Business Quant data.